Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48640
Campo DC Valoridioma
dc.contributor.authorYang, Kunen_US
dc.contributor.authorPuel, Anneen_US
dc.contributor.authorZhang, Shenyingen_US
dc.contributor.authorEidenschenk, Célineen_US
dc.contributor.authorKu, Cheng Lungen_US
dc.contributor.authorCasrouge, Armandaen_US
dc.contributor.authorPicard, Capucineen_US
dc.contributor.authorVon Bernuth, Horsten_US
dc.contributor.authorSenechal, Brigitteen_US
dc.contributor.authorPlancoulaine, Sabineen_US
dc.contributor.authorAl-Hajjar, Samien_US
dc.contributor.authorAl-Ghonaium, Abdulazizen_US
dc.contributor.authorMaródi, Lászlóen_US
dc.contributor.authorDavidson, Donalden_US
dc.contributor.authorSpeert, Daviden_US
dc.contributor.authorRoifman, Chaimen_US
dc.contributor.authorGarty, Ben Zionen_US
dc.contributor.authorOzinsky, Adrianen_US
dc.contributor.authorBarrat, Franck J.en_US
dc.contributor.authorCoffman, Robert L.en_US
dc.contributor.authorMiller, Richard L.en_US
dc.contributor.authorLi, Xiaoxiaen_US
dc.contributor.authorLebon, Pierreen_US
dc.contributor.authorRodriguez-Gallego, Carlosen_US
dc.contributor.authorChapel, Helenen_US
dc.contributor.authorGeissmann, Frédéricen_US
dc.contributor.authorJouanguy, Emmanuelleen_US
dc.contributor.authorCasanova, Jean Laurenten_US
dc.date.accessioned2018-11-23T23:39:05Z-
dc.date.available2018-11-23T23:39:05Z-
dc.date.issued2005en_US
dc.identifier.issn1074-7613en_US
dc.identifier.urihttp://hdl.handle.net/10553/48640-
dc.description.abstractFive TLRs are thought to play an important role in antiviral immunity, sensing viral products and inducing IFN-α/β and -λ. Surprisingly, patients with a defect of IRAK-4, a critical kinase downstream from TLRs, are resistant to common viruses. We show here that IFN-α/β and -λ induction via TLR-7, TLR-8, and TLR-9 was abolished in IRAK-4-deficient blood cells. In contrast, IFN-α/β and -λ were induced normally by TLR-3 and TLR-4 agonists. Moreover, IFN-β and -λ were normally induced by TLR-3 agonists and viruses in IRAK-4-deficient fibroblasts. We further show that IFN-α/β and -λ production in response to 9 of 11 viruses tested was normal or weakly affected in IRAK-4-deficient blood cells. Thus, IRAK-4-deficient patients may control viral infections by TLR-3- and TLR-4-dependent and/or TLR-independent production of IFNs. The TLR-7-, TLR-8-, and TLR-9-dependent induction of IFN-α/β and -λ is strictly IRAK-4 dependent and paradoxically redundant for protective immunity to most viruses in humans.en_US
dc.languageengen_US
dc.relation.ispartofImmunityen_US
dc.sourceImmunity[ISSN 1074-7613],v. 23, p. 465-478 (Noviembre 2005)en_US
dc.subject32 Ciencias médicasen_US
dc.subject3205 Medicina internaen_US
dc.subject.otherImmunityen_US
dc.subject.otherVirusesen_US
dc.titleHuman TLR-7-, -8-, and -9-mediated induction of IFN-α/β and -λ Is IRAK-4 dependent and redundant for protective immunity to virusesen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.immuni.2005.09.016en_US
dc.identifier.scopus27744534928-
dc.contributor.authorscopusid57198557043-
dc.contributor.authorscopusid6602102891-
dc.contributor.authorscopusid36019693200-
dc.contributor.authorscopusid6506271997-
dc.contributor.authorscopusid7101950604-
dc.contributor.authorscopusid6602132138-
dc.contributor.authorscopusid7101616884-
dc.contributor.authorscopusid55983430500-
dc.contributor.authorscopusid56202604600-
dc.contributor.authorscopusid6603497428-
dc.contributor.authorscopusid6701751894-
dc.contributor.authorscopusid6508014303-
dc.contributor.authorscopusid7005046352-
dc.contributor.authorscopusid7402300034-
dc.contributor.authorscopusid7005904786-
dc.contributor.authorscopusid7005910265-
dc.contributor.authorscopusid7006447332-
dc.contributor.authorscopusid6603379915-
dc.contributor.authorscopusid7004337083-
dc.contributor.authorscopusid57131500900-
dc.contributor.authorscopusid55574232667-
dc.contributor.authorscopusid57195873744-
dc.contributor.authorscopusid7102555618-
dc.contributor.authorscopusid6602114379-
dc.contributor.authorscopusid7005426128-
dc.contributor.authorscopusid7003428137-
dc.contributor.authorscopusid6701731774-
dc.contributor.authorscopusid7201863327-
dc.description.lastpage478en_US
dc.description.firstpage465en_US
dc.relation.volume23en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages14en_US
dc.utils.revisionen_US
dc.date.coverdateNoviembre 2005en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-4344-8644-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameRodríguez Gallego, José Carlos-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

245
actualizado el 17-nov-2024

Citas de WEB OF SCIENCETM
Citations

226
actualizado el 17-nov-2024

Visitas

63
actualizado el 06-jul-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.